Updated NCCN SCLC guidelines recommend testing patients with suspected PNS; however, researchers found screening uptake in the US is low.

Pembrolizumab plus EVX-01, a personalized peptide-based neoantigen cancer vaccine, demonstrated the “ability to induce potent and sustained T-cell responses” among patients with previously untreated, ...

Study validates FACIT-Fatigue scale for assessment of cancer-related fatigue in patients with locally advanced/metastatic breast cancer.

Smaller declines seen in early-stage cancer diagnosis during COVID-19 pandemic in adults aged 18 to 44 years, men, those with high comorbidity burden.

Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.

Investigators assessed the independent associations of albuminuria and eGFR with overall and site-specific cancers using data from more than one million patients in the Chronic Kidney Disease ...

In HR+/HER- early breast cancer, the DFS benefits of adjuvant ribociclib plus NSAI treatment compared to NSAI alone persisted even a year after treatment completion.

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline ...

HealthDay News — For patients with metastatic castration-sensitive prostate cancer (mCSPC) with homologous recombination repair (HRR) gene alterations, the addition of niraparib to abiraterone acetate ...

Patients with 15-day MRD less than 10% blasts fared better than those with 10% or greater, even if they had other high-risk factors.

Our prediction model provides a useful framework for conveying tailored risk information simply and identifying women who may receive enhanced benefit from specific intervention strategies because ...